These final results, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 help the concept of focusing on ACKR3 as a novel technique to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked disorders.(2) The medical professional has g